{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-103498","form_type":"8-K","ticker":"ATNM","cik":"0001388320","company_name":"Actinium Pharmaceuticals, Inc.","filed_at":"2024-11-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.317073+00:00","generated_at":"2026-05-29T13:44:54.766999+00:00","sec_items":["5.02","5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Actinium re-elects Class II directors Seth and Chell, ratifies Marcum as auditor at 2024 annual meeting","bullets":["Sandesh Seth and Jeffrey W. Chell re-elected as Class II directors for three-year terms expiring at 2027 annual meeting.","Marcum LLP ratified as independent registered public accounting firm for fiscal year ending Dec 31, 2024.","Approximately 63.2% of outstanding shares (19.7M of 31.2M) were represented at the meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-103498","json":"https://secwatch.observer/filing/0001213900-24-103498.json","markdown":"https://secwatch.observer/filing/0001213900-24-103498.md","text":"https://secwatch.observer/filing/0001213900-24-103498.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1388320/000121390024103498/0001213900-24-103498-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1388320/000121390024103498/ea0222950-8k_actinium.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T13:44:54.766999+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}